
JW Pharma confronts a potential 30 Billion Won ($21 million) fine amid allegations of unlawful rebates
On Thursday, the antitrust regulator announced a hefty fine of 29.8 billion won (approximately US$21.93 million) for JW Pharmaceutical, a domestic pharmaceutical company, for allegedly [more…]